Margaux Lafaurie

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study.

Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study.

Journal: British journal of haematology

Published: April 20, 2026

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Journal: Blood advances

Published: March 27, 2026

No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study.

No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study.

Journal: Haematologica

Published: November 10, 2025

Risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag vs romiplostim: a target trial emulation in the French Adult Immune Thrombocytopenia (FAITH) cohort.

Risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag vs romiplostim: a target trial emulation in the French Adult Immune Thrombocytopenia (FAITH) cohort.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 22, 2025

Socioeconomic deprivation, disease complications and access to preventive care in sickle cell disease in mainland France.

Socioeconomic deprivation, disease complications and access to preventive care in sickle cell disease in mainland France.

Journal: Annals of hematology

Published: October 02, 2025

Early initiation of sodium-glucose co-transporter-2 inhibitors in heart failure patients: a nationwide study.

Early initiation of sodium-glucose co-transporter-2 inhibitors in heart failure patients: a nationwide study.

Journal: ESC heart failure

Published: August 04, 2025

Risk of cancer in adults with primary immune thrombocytopenia: a binational population-based realworld cohort study from Denmark and France.

Risk of cancer in adults with primary immune thrombocytopenia: a binational population-based realworld cohort study from Denmark and France.

Journal: Haematologica

Published: January 14, 2025

Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure Patients: A Nationwide Population-Based Cohort Study.

Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure Patients: A Nationwide Population-Based Cohort Study.

Journal: JACC. Heart failure

Published: November 06, 2024

Shaping the future of pharmacoepidemiology in France: Recommendations from the SFPT Pharmacoepidemiology Working Group.

Shaping the future of pharmacoepidemiology in France: Recommendations from the SFPT Pharmacoepidemiology Working Group.

Journal: Therapie

Published: September 26, 2024

Use of real-world data for the development and the follow-up of drugs in rare diseases. The example of immune thrombocytopenia and autoimmune hemolytic anemia.

Use of real-world data for the development and the follow-up of drugs in rare diseases. The example of immune thrombocytopenia and autoimmune hemolytic anemia.

Journal: La Revue de medecine interne

Published: September 01, 2024

Drug-induced immune thrombocytopenia: When both oxaliplatin and methylprednisolone are the culprits

Drug-induced immune thrombocytopenia: When both oxaliplatin and methylprednisolone are the culprits

Journal: La Revue de medecine interne

Published: August 14, 2024

Risk of hospitalization with infection in adults with primary AIHA treated with rituximab: a French nationwide study.

Risk of hospitalization with infection in adults with primary AIHA treated with rituximab: a French nationwide study.

Journal: Blood advances

Published: March 11, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026